Neurocrine Biosciences
NBIX
#1239
Rank
C$20.52 B
Marketcap
$202.73
Share price
1.43%
Change (1 day)
14.00%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): $2.63

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is $2.81. In 2022 the company made an earnings per share (EPS) of $2.31 an increase over its 2021 EPS that were of $1.36.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.6314.19%
2022$2.3169.47%
2021$1.36-78.21%
2020$6.25990%
2019$0.5781.82%
2018$0.32-113.5%
2017-$2.340.62%
2016-$2.3257.28%
2015-$1.4825.61%
2014-$1.1718.84%
2013-$0.99-1085.71%
2012$0.10-89.71%
2011$0.97-500%
2010-$0.24-86.92%
2009-$1.86-43.48%
2008-$3.30-57.8%
2007-$7.8192.58%
2006-$4.05371.67%
2005-$0.86-52.76%
2004-$1.8236.56%
2003-$1.33-70%
2002-$4.44118.31%
2001-$2.038.4%
2000-$1.8848.86%
1999-$1.26-20%
1998-$1.58-479.31%
1997$0.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.99 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.79-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$4.24-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.78 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.27 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.66-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.67-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.34-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA